Introduction to Two Double Blind

What is/are Two Double Blind?

Two Double Blind - METHODS Participants (N = 41) completed two double-blinded and counterbalanced functional magnetic resonance imaging (fMRI) sessions: one after taking naltrexone (50 mg/day) for four days and one after taking placebo for four days. ^[1] METHODS Two double-blinded studies including 30 patients with type 2 diabetes (T2D) and 20 healthy individuals were conducted. ^[2] Methods Two double-blind, randomized, controlled, split-face intra-individual studies were conducted during summer months in Barcelona. ^[3] MethodsIn two double-blind, randomized and placebo-controlled experiments (experiment 1: N = 79, experiment 2: N = 32) comprising fear conditioning (day 1), extinction followed by administration of 150 mg L-DOPA or placebo (day 2) and a memory test (day 3) in healthy male adults, conditioned responses were assessed as differential skin conductance responses. ^[4] 05% lotion or vehicle in two double-blind placebo-controlled 12-week studies. ^[5] 2D and 3D LV tissue tracking analysis were performed in a random fashion by two double-blinded operators. ^[6] Two double-blind clinical trials reported no differences in efficacy and safety profiles between maintenance group (INF/INF) and interchangeability group in all diseases included (INF/CTP-13) and rheumatoid arthritis (CTP13 and SB2). ^[7] METHODS First episode major depression (DSM-III-R) outpatients who completed 6 weeks in two double-blind randomized trials with fluoxetine and desipramine were crossed over to treatment with the other drug under open conditions for 6 weeks. ^[8] MethodsData were pooled from two double-blind, placebo-controlled phase 3 trials; EVOLVE-1 and EVOLVE-2. ^[9] In two double-blind, multinational, phase III studies, CCH improved the physical (penile curvature) and psychological (patient-reported bother) aspects of PD in adult men. ^[10] In The Lancet, Claus Bachert and colleagues report the results of two double-blind, placebo-controlled phase 3 trials (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52) assessing the efficacy of dupilumab when added to standard-of-care therapy (intranasal corticosteroids) in adults with severe uncontrolled CRSwNP who previously did not have results with or had contraindications to systemic corticosteroids, surgery, or both. ^[11] Methods Lipopolysaccharide injections were used to provoke acute systemic inflammatory responses in healthy men and women and were compared to placebo in two double-blind randomized experiments. ^[12] METHODS We completed two double-blind, placebo-controlled trials of SNRI antidepressant medications with MRI scans obtained before and after treatment. ^[13] 2 In The Lancet Respiratory Medicine , Charles Haworth and colleagues 3 report promising data from two double-blind randomised controlled trials (ORBIT-3 and ORBIT-4) examining the efficacy of a once-daily inhaled antibiotic composed of liposome-encapsulated ciprofloxacin and free ciprofloxacin (ARD-3150), which is a welcome advancement in the bronchiectasis field in which few such trials exist. ^[14] Whole-body CT examinations were read by two double-blinded readers to help detect unsuspected injuries. ^[15] A new host-response assay (ImmunoXpert™) that integrates the levels of three proteins (TRAIL, IP-10, and CRP) was shown to exhibit high performance in distinguishing between bacterial and viral disease in two double-blind validation studies. ^[16] Mothers with bonding difficulties (n=68) will be randomised to one of two double-blind intervention groups at 4–6 months postpartum. ^[17] 75% concentration in two double-blind, randomized, placebocontrolled, phase 3 trials for the treatment of hyperhidrosis. ^[18] Objective: The aim of this post hoc cumulative responder analysis was to examine the nasal congestion response in detail by depicting the level of response obtained in two double-blind, placebo controlled studies of mometasone furoate nasal spray (MFNS) therapy for SAR, conducted from August to October 2008 at U. ^[19] METHODS We carried out two double-blind, placebo-controlled clinical trials of N-methyl-D-aspartate receptor augmentation of psychotropic drug treatment in these two individuals. ^[20] Results: Sixty-two double-blind randomized clinical trials studying 2914 patients with schizophrenia met the inclusion criteria for quantitative analysis. ^[21] Design Hypopituitary patients on stable replacement with hydrocortisone and growth hormone were investigated in two double-blind and placebo-controlled crossover studies. ^[22] Stainings were quantified using the ODPviewer® software (Kamax Innovative System, France) by two double-blind observers. ^[23] Methods: We conducted two double-blind, within-subjects studies examining impairments after oral doses of ∆9-tetrahydrocannabinol (0, 7. ^[24] DESIGN We explored the effect of intranasal OT (inOT) on nonverbal synchrony in sixteen patients with BPD and fifteen healthy controls (CTL) randomly assigned to two double-blind clinical interviews under inOT and placebo (PL). ^[25]